Our expertise in this area is recognised globally, and we hold leadership positions in international bodies that set treatment directions for CLL, extranodal lymphoma, Waldenstrom macroglobulinemia and hairy cell leukaemia. Members from our team are pivotal in bringing highly active groups of drugs such as next-generation monoclonal antibodies (obinutuzumab), BTK inhibitors (ibrutinib) and BCL2 antagonists (venetoclax) to the clinic and continue to lead innovative research into new treatments for blood cancers.
Low grade lymphoma, chronic lymphocytic leukaemia and related disease referrals
Visit the Refer a patient page for more information
Clinics
This low grade lymphoma, chronic lymphocytic leukaemia and related disease service runs clinics on Wednesday and Friday mornings. Clinics are held in the Peter Mac building on Grattan Street in Melbourne.
Go back to the Clinical Haematology information for health professionals page